Furthermore, our study suggests that loss of TMIGD1 in human cancers, which was previously reported in renal and colon cancers [5, 10, 27], could result in the activation of pro-tumorigenic signaling cascades, including the activation of ERM proteins that contribute to tumor progression. Here, ETV5 is linked to neoplasm.